This is called dose titration and its exact application varies from drug to drug
Diabetes Care 37(4):10691075
Regional Insights: North America led the global incretin mimetics market in 2024, driven by a high prevalence of type 2 diabetes, robust healthcare systems, high disposable income, and early adoption of new treatments
Lundkvist P, Pereira MJ, Katsogiannos P, Sjstrm CD, Johnsson E, Eriksson JW
The risk of neovascular AMD among semaglutide users was similar to users of dulaglutide (condition codes alone, hazard ratio [HR]: 0.57
We understand the complex nature of disordered eating and eating disorders and strongly encourage anyone engaging in these behaviors to reach out for help as soon as possible